Clinical Trial Update: Use of Corifolitropin Alfa in Oocyte Donors [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on the use of corifolitropin alfa in oocyte donors. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Corifolitropin Alfa (corifolitropin alfa)

Snippet

Sponsor: IVI Madrid | Conditions: Female Reproductive Problem, Infertility | Phase 4 | Status: UNKNOWN